Sfoglia per AUTORE
RASPAGLIESI F
Collezione AO Ordine Mauriziano

  

Items : 13

A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer". in Future oncology (London, England) / Future Oncol. 2025 Jan;21(2):151-168. doi: 10.2217/fon-2023-0940. Epub 2024 Jul 11.
2025
AO Ordine Mauriziano

Mirza MR; Chase DM; Slomovitz BM; Christensen RD; Novák Z; Black D; Gilbert L; Sharma S; Valabrega G; Landrum LM; Hanker LC; Stuckey A; Boere I; Gold MA; Auranen A; Pothuri B; Cibula D; McCourt C; Raspagliesi F; Shahin MS; Gill SE; Monk BJ; Buscema J; Herzog TJ; Copeland LJ; Tian M; He Z; Stevens S; Zografos E; et alii...

SUCCOR 10 years: a decade's perspective on radical hysterectomy outcomes in cervical cancer. in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society / Int J Gynecol Cancer. 2025 Feb 6:101690. doi: 10.1016/j.ijgc.2025.101690.
2025
AO Ordine Mauriziano

Manzour N; Chiva L; Zanagnolo V; C?pîlna ME; Bizzarri N; Mom CH; Klasa ?; Arencibia O; Malzoni M; Narducci F; Raspagliesi F; Poka R; Golub D; Tavares M; Tsolakidis D; Shamistan A; Perrone AM; Pete I; Aluloski I; Bernardino M; Vuji? G; Jedryka M; Maenpaa M; Ponce J; Povolotskaya N; Roldan Rivas F; Feron JG; Van Gorp T; Alonso-Espías M; et alii...

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 May 1;42(13):1488-1498. doi: 10.1200/JCO.23.01225. Epub 2024 Feb 5.
2024
AO Ordine Mauriziano

Lorusso D; Raspagliesi F; Ronzulli D; Valabrega G; Colombo N; Pisano C; Cassani C; Tognon G; Tamberi S; Mangili G; Mammoliti S; De Giorgi U; Greco F; Mosconi AM; Breda E; Artioli G; Andreetta C; Casanova C; Ceccherini R; Frassoldati A; Salutari V; Giolitto S; Scambia G;

Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial. in Gynecologic oncology / Gynecol Oncol. 2023 May;172:72-77. doi: 10.1016/j.ygyno.2023.03.011. Epub 2023 Mar 23.
2023
AO Ordine Mauriziano

Musacchio L; Turinetto M; Arenare L; Bartoletti M; Califano D; Tuninetti V; Marchetti C; Cormio G; Loizzi V; Pisano C; Salutari V; Valabrega G; Priolo D; Cecere SC; Ventriglia J; Raspagliesi F; Perrone F; Fagotti A; Lorusso D; Scambia G; Pignata S;

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer. in The New England journal of medicine / N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27.
2023
AO Ordine Mauriziano

Mirza MR; Chase DM; Slomovitz BM; dePont Christensen R; Novák Z; Black D; Gilbert L; Sharma S; Valabrega G; Landrum LM; Hanker LC; Stuckey A; Boere I; Gold MA; Auranen A; Pothuri B; Cibula D; McCourt C; Raspagliesi F; Shahin MS; Gill SE; Monk BJ; Buscema J; Herzog TJ; Copeland LJ; Tian M; He Z; Stevens S; Zografos E; et alii...

2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Borsotti L; Paolini B; Puppo A; Marinaccio M; Cormio G; Carella C; Mandato VD; Parisi A; Sikokis A; Biglia N; Mammoliti S; Zanchi L; Artioli G; Maldi E; Andreetta C; Raspagliesi F; Picardo E; Pignata S; Ghisoni E; Tuninetti V; Scotto G; Turinetto M; Sangiolo D; Di Maio M; Valabrega G;

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Dec 10;41(35):5400-5410. doi: 10.1200/JCO.22.02906. Epub 2023 Sep 5.
2023
AO Ordine Mauriziano

Vergote I; Pérez-Fidalgo JA; Hamilton EP; Valabrega G; Van Gorp T; Sehouli J; Cibula D; Levy T; Welch S; Richardson DL; Guerra EM; Scambia G; Henry S; Wimberger P; Miller DS; Klat J; Martínez-Garcia J; Raspagliesi F; Pothuri B; Romero I; Bergamini A; Slomovitz B; Schochter F; Høgdall E; Fariñas-Madrid L; Monk BJ; Michel D; Kauffman MG; Shacham S; et alii...

Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer. in Gynecologic oncology / Gynecol Oncol. 2022 Sep;166(3):561-566. doi: 10.1016/j.ygyno.2022.07.022. Epub 2022 Jul 29.
2022
AO Cuneo
AO Ordine Mauriziano
AOU Novara

Raspagliesi F; Muzii L; Panici PB; Ghezzi F; Landoni F; Scambia G; Donato VD; Bogani G;

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22). in British journal of cancer / Br J Cancer. 2022 Nov;127(8):1479-1486. doi: 10.1038/s41416-022-01897-1. Epub 2022 Jul 22.
2022
AO Ordine Mauriziano

Musacchio L; Califano D; Bartoletti M; Arenare L; Lorusso D; Losito NS; Cormio G; Greggi S; Raspagliesi F; Valabrega G; Salutari V; Pisano C; Spina A; Russo D; Del Sesto M; Canzonieri V; Ferraù F; Zannoni GF; Loizzi V; Ghizzoni V; Casanova C; Tuninetti V; Ducceschi M; Del Vecchio V; Scalone S; Priolo D; Perrone F; Scambia G; Pignata S; et alii...

Gynecological Cancers in Lynch Syndrome: A Comparison of the Histological Features with Sporadic Cases of the General Population. in Journal of clinical medicine / J Clin Med. 2022 Jun 27;11(13):3689. doi: 10.3390/jcm11133689.
2022
ASL Cuneo 2
ASL Città di Torino
ASL Torino 3
AO Ordine Mauriziano

Biglia N; Ditto A; Vitellaro M; Raspagliesi F; Tomasi Cont N; Ricci MT; Pasini B; Bounous VE; Robba E; Perotto S;

Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic. in Journal of gynecologic oncology / J Gynecol Oncol. 2022 Jan;33(1):e10. doi: 10.3802/jgo.2022.33.e10. Epub 2021 Nov 12.
2022
AO Cuneo
AO Ordine Mauriziano
AOU Novara

Benedetti Panici P; Beretta P; Ruscitto F; Remorgida V; Rosati M; Surico D; Gallo C; Palomba S; Calandra D; Mandato VD; Aguzzoli L; D'Ippolito G; Tinelli R; Cantaluppi S; Lippolis A; Consonni R; Trojano G; Romano F; Ricci G; Cicogna S; Fambrini M; Tateo S; Sorbi F; Mereu L; Giannella L; Delli Carpini G; Capobianco G; Ciavattini A; Vercellini P; et alii...

Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial. in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society / Int J Gynecol Cancer. 2021 Oct;31(10):1348-1355. doi: 10.1136/ijgc-2021-002786. Epub 2021 Aug 30.
2021
AO Ordine Mauriziano

Gallo C; Schettino C; Gargiulo P; Greggi S; Distefano M; Bogani G; Nardin M; Lapresa M; Cecere SC; Salutari V; Lorusso D; Katsaros D; Lissoni AA; Scollo P; De Giorgi U; Cinieri S; De Censi A; Breda E; Ferrero A; Lauria R; Gadducci A; Tognon G; Artioli G; Frezzini S; Colombo N; Pisano C; Scambia G; Raspagliesi F; Arenare L; et alii...

Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study. in European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology / Eur J Surg Oncol. 2014 Jul;40(7):891-8. doi: 10.1016/j.ejso.2013.11.026. Epub 2013 Dec 14.
2014
AO Ordine Mauriziano

Ferrero A; Ditto A; Giorda G; Gadducci A; Greggi S; Daniele A; Fuso L; Panuccio E; Scaffa C; Raspagliesi F; Sismondi P; Biglia N;